Clovis Oncology Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Employees
-
368
- Latest Deal Type
-
Liquidation
Clovis Oncology General Information
Description
Operator of a biotechnology company intended to serve the United States, Europe and other international markets. The company specializes in acquiring, developing and commercializing cancer treatments and diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use, thereby delivering the right drug to the right patient at the right time.
Contact Information
Website
www.clovisoncology.comCorporate Office
- 5500 Flatiron Parkway
- Suite 100
- Boulder, CO 80301
- United States
Corporate Office
- 5500 Flatiron Parkway
- Suite 100
- Boulder, CO 80301
- United States
Clovis Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 11-Jul-2023 | Completed | Bankruptcy: Liquidation | |||
| 9. Merger/Acquisition | 14-Jun-2022 | Cancelled | Generating Revenue | |||
| 8. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 7. PIPE | 26-Nov-2013 | Completed | Startup | |||
| 6. IPO | 16-Nov-2011 | Completed | Generating Revenue | |||
| 5. Debt - General | 01-Jun-2011 | Completed | Startup | |||
| 4. Early Stage VC (Series B) | 18-Nov-2009 | Completed | Startup | |||
| 3. Early Stage VC (Series A2) | 09-Nov-2009 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 25-Jun-2009 | $146M | $156M | Completed | Startup | |
| 1. Early Stage VC (Series A1) | 15-May-2009 | $10.1M | $10.1M | Completed | Startup |
Clovis Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 5,044,828 | $0.001000 | $0.16 | $2 | $2 | 1x | $2 | 11.82% |
Clovis Oncology Comparisons
Industry
Financing
Details
Clovis Oncology Competitors (84)
One of Clovis Oncology’s 84 competitors is Agenus, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Cardiff Oncology | Formerly Angel backed | San Diego, CA |
Clovis Oncology Patents
Clovis Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021254793-A1 | Immunostimulatory agents in combination with angiogenesis inhibitors | Inactive | 15-Apr-2020 | ||
| CA-3175356-A1 | Immunostimulatory agents in combination with angiogenesis inhibitors | Pending | 15-Apr-2020 | ||
| EP-4135752-A1 | Immunostimulatory agents in combination with angiogenesis inhibitors | Inactive | 15-Apr-2020 | ||
| EP-4135752-A4 | Immunostimulatory agents in combination with angiogenesis inhibitors | Inactive | 15-Apr-2020 | ||
| US-20210338656-A1 | Immunostimulatory agents in combination with angiogenesis inhibitors | Inactive | 15-Apr-2020 | A61K31/47 |
Clovis Oncology Signals
Clovis Oncology Acquisitions (1)
Clovis Oncology’s most recent deal was a Merger/Acquisition with E.O.S for . The deal was made on 19-Nov-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| E.O.S | 19-Nov-2013 | Merger/Acquisition | Drug Discovery |
Clovis Oncology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Clovis Oncology FAQs
-
When was Clovis Oncology founded?
Clovis Oncology was founded in 2009.
-
Where is Clovis Oncology headquartered?
Clovis Oncology is headquartered in Boulder, CO.
-
What is the size of Clovis Oncology?
Clovis Oncology has 368 total employees.
-
What industry is Clovis Oncology in?
Clovis Oncology’s primary industry is Biotechnology.
-
Is Clovis Oncology a private or public company?
Clovis Oncology is a Private company.
-
What is Clovis Oncology’s current revenue?
The current revenue for Clovis Oncology is .
-
How much funding has Clovis Oncology raised over time?
Clovis Oncology has raised $558M.
-
Who are Clovis Oncology’s competitors?
Agenus, Immunocore Holdings, Fate Therapeutics, Ayala Pharmaceuticals, and Cardiff Oncology are some of the 84 competitors of Clovis Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process